Retroviral vectors for transducing .beta.-globin gene and .beta.-locus control region derivatives
AssigneeMassachusetts Institute of Technology
InventorsPhilippe LeBoulch, Irving M. London, Dorothy Tuan
Life of this patent
Estimating the term…
Loading patent…
AssigneeMassachusetts Institute of Technology
InventorsPhilippe LeBoulch, Irving M. London, Dorothy Tuan
Estimating the term…
A process and means for the design and the optimization of retroviral vectors transducing human .beta.-globin gene and .beta.-Locus Control Region (.beta.-LCR) derivatives, hereafter referred to as [.beta.-globin/LCR] retroviruses, which successfully meet the following criteria required for gene therapy applications: (1) stability of proviral transmission (low frequency of rearrangements similar to retroviral vectors considered stable in the art) upon infection of cell-lines and murine bone marrow cells, (2) improved viral titer, thereby allowing successful infection of bone marrow cells, and (3) high erythroid expression of the transduced human .beta.-globin gene, are described, along with specific constructs.
A method of making a retroviral vector for transducing .beta.-globin genes and .beta.-LCR sequences comprising the steps of:
A retroviral vector for transducing .beta.-globin genes and .beta.-LCR sequences comprising:
Dependencies are inferred from the claim text.